Cite
HARVARD Citation
Fevery, J. et al. (2016). Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD. Alimentary pharmacology & therapeutics. 43 (5), pp. 612-620. [Online].